Clinical Trial Update: A Single-Center Clinical Study to Evaluate the Efficacy and Safety of Autologous Urine-Derived Epithelial Cells in the Treatment of Corneal Endothelial Cell Dysfunction [NA]

View source ↗

Summary

A single-center study is evaluating autologous urine-derived epithelial cells for corneal endothelial dysfunction; the trial is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Endothelial Dysfunction

Drugs mentioned

• Autologous urine-derived epithelial cells

Snippet

Sponsor: Suxia Li | Conditions: Cornea Disease | NA | Status: NOT_YET_RECRUITING